South Korea · Delayed Price · Currency is KRW Boditech Med Statistics
Total Valuation
Boditech Med has a market cap or net worth of KRW 320.43 billion. The enterprise value is 283.96 billion.
| Market Cap | 320.43B |
| Enterprise Value | 283.96B |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
Boditech Med has 21.78 million shares outstanding. The number of shares has decreased by -0.58% in one year.
| Current Share Class | 21.78M |
| Shares Outstanding | 21.78M |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 39.17% |
| Owned by Institutions (%) | 1.28% |
| Float | 13.13M |
Valuation Ratios
The trailing PE ratio is 12.59 and the forward PE ratio is 9.88.
| PE Ratio | 12.59 |
| Forward PE | 9.88 |
| PS Ratio | 2.14 |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | 23.46 |
| P/OCF Ratio | 12.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.25, with an EV/FCF ratio of 20.79.
| EV / Earnings | 11.12 |
| EV / Sales | 1.90 |
| EV / EBITDA | 7.25 |
| EV / EBIT | 9.53 |
| EV / FCF | 20.79 |
Financial Position
The company has a current ratio of 5.69, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.69 |
| Quick Ratio | 3.89 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.62 |
| Interest Coverage | 76.55 |
Financial Efficiency
Return on equity (ROE) is 11.29% and return on invested capital (ROIC) is 7.38%.
| Return on Equity (ROE) | 11.29% |
| Return on Assets (ROA) | 6.84% |
| Return on Invested Capital (ROIC) | 7.38% |
| Return on Capital Employed (ROCE) | 11.78% |
| Revenue Per Employee | 276.15M |
| Profits Per Employee | 47.20M |
| Employee Count | 541 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, Boditech Med has paid 4.55 billion in taxes.
| Income Tax | 4.55B |
| Effective Tax Rate | 15.08% |
Stock Price Statistics
The stock price has decreased by -20.96% in the last 52 weeks. The beta is 0.12, so Boditech Med's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -20.96% |
| 50-Day Moving Average | 14,202.40 |
| 200-Day Moving Average | 15,547.50 |
| Relative Strength Index (RSI) | 58.79 |
| Average Volume (20 Days) | 79,112 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Boditech Med had revenue of KRW 149.40 billion and earned 25.53 billion in profits. Earnings per share was 1,168.13.
| Revenue | 149.40B |
| Gross Profit | 86.96B |
| Operating Income | 27.99B |
| Pretax Income | 30.14B |
| Net Income | 25.53B |
| EBITDA | 37.38B |
| EBIT | 27.99B |
| Earnings Per Share (EPS) | 1,168.13 |
Balance Sheet
The company has 58.13 billion in cash and 8.44 billion in debt, giving a net cash position of 49.69 billion or 2,281.02 per share.
| Cash & Cash Equivalents | 58.13B |
| Total Debt | 8.44B |
| Net Cash | 49.69B |
| Net Cash Per Share | 2,281.02 |
| Equity (Book Value) | 233.61B |
| Book Value Per Share | 10,117.26 |
| Working Capital | 112.16B |
Cash Flow
In the last 12 months, operating cash flow was 25.22 billion and capital expenditures -11.56 billion, giving a free cash flow of 13.66 billion.
| Operating Cash Flow | 25.22B |
| Capital Expenditures | -11.56B |
| Free Cash Flow | 13.66B |
| FCF Per Share | 627.14 |
Margins
Gross margin is 58.20%, with operating and profit margins of 18.74% and 17.09%.
| Gross Margin | 58.20% |
| Operating Margin | 18.74% |
| Pretax Margin | 20.18% |
| Profit Margin | 17.09% |
| EBITDA Margin | 25.02% |
| EBIT Margin | 18.74% |
| FCF Margin | 9.14% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.02%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 1.02% |
| Dividend Growth (YoY) | -25.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 12.80% |
| Buyback Yield | 0.58% |
| Shareholder Yield | 1.61% |
| Earnings Yield | 7.97% |
| FCF Yield | 4.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 5, 2017 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Boditech Med has an Altman Z-Score of 10.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.25 |
| Piotroski F-Score | 5 |